Hu Ziying, Zhang Chengdong, Wang Daqi, Gao Siqi, Ong Sang-Ging, Wang Yongming, Zheng Wei V
State Key Laboratory of Genetic Engineering, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China.
Centre for Assisted Reproduction, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China.
Front Cell Dev Biol. 2021 Nov 11;9:771248. doi: 10.3389/fcell.2021.771248. eCollection 2021.
CRISPR/Cas9 nucleases hold great potential for gene therapy, but they frequently induce unwanted off-target cleavage. We previously developed a GFP activation assay for detection of DNA cleavage in cells. Here, we demonstrate two novel applications of this assay. First, we use this assay to confirm off-target cleavage that cannot be detected by targeted deep sequencing in cells before. Second, we use this approach to detect multiple alternative PAMs recognized by SpCas9. These noncanonical PAMs are associated with low cleavage activity, but targets associated with these PAMs must be considered as potential off-target sites. Taken together, the GFP activation assay is a powerful platform for DNA cleavage detection in cells.
CRISPR/Cas9核酸酶在基因治疗方面具有巨大潜力,但它们经常会引发不必要的脱靶切割。我们之前开发了一种用于检测细胞中DNA切割的绿色荧光蛋白(GFP)激活检测方法。在此,我们展示了该检测方法的两种新应用。首先,我们使用此检测方法来确认之前在细胞中通过靶向深度测序无法检测到的脱靶切割。其次,我们使用这种方法来检测被SpCas9识别的多个替代性原间隔序列临近基序(PAM)。这些非规范PAM与低切割活性相关,但与这些PAM相关的靶点必须被视为潜在的脱靶位点。综上所述,GFP激活检测方法是用于检测细胞中DNA切割的强大平台。